Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...
These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population—add to previously published evidence of its strong ...
Philips and Masimo have renewed a longstanding strategic partnership to develop patient care solutions. This time, the companies stated that their collaboration would primarily focus on advancing ...
A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...
Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results